Sonablate, a medical technology company focused on non-invasive prostate cancer treatment using high-intensity focused ultrasound (HIFU) , today announced the appointment of Brad Saar, former ...
EDAP TMS SA announced the successful treatment of the first patient in its phase I/II PULS Trial, which is investigating the use of High Intensity Focused Ultrasound (HIFU) technology for pancreatic ...
AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored ...
LYON, France, October 1, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, today announced that the first patients have been treated in a Phase I/II study evaluating the ...
Hosted on MSN
Edap targets $50M–$54M HIFU revenue for 2026 with continued US and international expansion
Earnings Call Insights: EDAP TMS S.A. (EDAP) Q4 2025 Management reiterated 2026 guidance, stating, "we expect core HIFU revenue to be in the range of USD 50 million to USD 54 million, representing 34% ...
Semi-Live Focal One Procedure to be Conducted on August 15 t h at 5:00 pm (KST) LYON, France, August 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today ...
Sonire Therapeutics raised $18 million in a Series A financing round to support its high-intensity focused ultrasound (HIFU) therapy system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results